Cargando…

End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study

INTRODUCTION: Adherence to HIV prevention methods is a challenge, particularly for young women in Sub‐Saharan Africa. End‐user research during product development can inform modifiable factors to increase future uptake and adherence. METHODS: Preferences for four vaginally inserted placebo HIV preve...

Descripción completa

Detalles Bibliográficos
Autores principales: Montgomery, Elizabeth T, Beksinska, Mags, Mgodi, Nyaradzo, Schwartz, Jill, Weinrib, Rachel, Browne, Erica N, Mphili, Nonhlanhla, Musara, Petina, Jaggernath, Manjeetha, Ju, Susan, Smit, Jenni, Chirenje, Z Mike, Doncel, Gustavo F, van der Straten, Ariane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506690/
https://www.ncbi.nlm.nih.gov/pubmed/31069957
http://dx.doi.org/10.1002/jia2.25283
_version_ 1783416899372056576
author Montgomery, Elizabeth T
Beksinska, Mags
Mgodi, Nyaradzo
Schwartz, Jill
Weinrib, Rachel
Browne, Erica N
Mphili, Nonhlanhla
Musara, Petina
Jaggernath, Manjeetha
Ju, Susan
Smit, Jenni
Chirenje, Z Mike
Doncel, Gustavo F
van der Straten, Ariane
author_facet Montgomery, Elizabeth T
Beksinska, Mags
Mgodi, Nyaradzo
Schwartz, Jill
Weinrib, Rachel
Browne, Erica N
Mphili, Nonhlanhla
Musara, Petina
Jaggernath, Manjeetha
Ju, Susan
Smit, Jenni
Chirenje, Z Mike
Doncel, Gustavo F
van der Straten, Ariane
author_sort Montgomery, Elizabeth T
collection PubMed
description INTRODUCTION: Adherence to HIV prevention methods is a challenge, particularly for young women in Sub‐Saharan Africa. End‐user research during product development can inform modifiable factors to increase future uptake and adherence. METHODS: Preferences for four vaginally inserted placebo HIV prevention methods were assessed among Zimbabwean and South African young women using a crossover clinical design. For each of months 1 to 4, participants were asked to use a pre‐coitally inserted film, insert (vaginal tablet) and gel once/week for a month, and a monthly ring in a randomly assigned sequence. Participants subsequently chose one preferred product to use as directed for the final study month. Women ranked the four products from most preferred to least preferred at enrolment and after trying all products. RESULTS: A total of 200 women aged 18 to 30 (mean 23) were enrolled; 178 (89%) completed follow‐up. At baseline, 41% of participants selected the gel as their most preferred product and 61% selected the ring as least preferred. During the crossover period, most (82% to 85%) self‐reported using each product at least once a week, although only half the time with sex. Objective biomarker data confirmed adequate use of all products. After trying each product, rankings changed with the film, ring, insert and gel being selected by 29%, 28%, 26% and 16% respectively. Choice varied significantly by country (p < 0.001): More Zimbabweans chose the film (45%), and more South Africans chose the insert (34%). Among women choosing the ring, 88% reported using it every time with sex. By contrast, self‐reported adherence was lower for “on‐demand” (coitally associated) products, with 40% to 55% using them every time during sex (p < 0.001). CONCLUSIONS: Preferences for these four dosage forms varied before and after use, and both within and across countries – there was no clear favourite – indicating the need for a range of options for end‐users The ring's popularity increased the most with use, was the second most preferred delivery system, and per self‐report, provided more coverage during sex. These end‐user perspectives provide important information to product developers and funding agencies.
format Online
Article
Text
id pubmed-6506690
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65066902019-05-13 End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study Montgomery, Elizabeth T Beksinska, Mags Mgodi, Nyaradzo Schwartz, Jill Weinrib, Rachel Browne, Erica N Mphili, Nonhlanhla Musara, Petina Jaggernath, Manjeetha Ju, Susan Smit, Jenni Chirenje, Z Mike Doncel, Gustavo F van der Straten, Ariane J Int AIDS Soc Research Articles INTRODUCTION: Adherence to HIV prevention methods is a challenge, particularly for young women in Sub‐Saharan Africa. End‐user research during product development can inform modifiable factors to increase future uptake and adherence. METHODS: Preferences for four vaginally inserted placebo HIV prevention methods were assessed among Zimbabwean and South African young women using a crossover clinical design. For each of months 1 to 4, participants were asked to use a pre‐coitally inserted film, insert (vaginal tablet) and gel once/week for a month, and a monthly ring in a randomly assigned sequence. Participants subsequently chose one preferred product to use as directed for the final study month. Women ranked the four products from most preferred to least preferred at enrolment and after trying all products. RESULTS: A total of 200 women aged 18 to 30 (mean 23) were enrolled; 178 (89%) completed follow‐up. At baseline, 41% of participants selected the gel as their most preferred product and 61% selected the ring as least preferred. During the crossover period, most (82% to 85%) self‐reported using each product at least once a week, although only half the time with sex. Objective biomarker data confirmed adequate use of all products. After trying each product, rankings changed with the film, ring, insert and gel being selected by 29%, 28%, 26% and 16% respectively. Choice varied significantly by country (p < 0.001): More Zimbabweans chose the film (45%), and more South Africans chose the insert (34%). Among women choosing the ring, 88% reported using it every time with sex. By contrast, self‐reported adherence was lower for “on‐demand” (coitally associated) products, with 40% to 55% using them every time during sex (p < 0.001). CONCLUSIONS: Preferences for these four dosage forms varied before and after use, and both within and across countries – there was no clear favourite – indicating the need for a range of options for end‐users The ring's popularity increased the most with use, was the second most preferred delivery system, and per self‐report, provided more coverage during sex. These end‐user perspectives provide important information to product developers and funding agencies. John Wiley and Sons Inc. 2019-05-09 /pmc/articles/PMC6506690/ /pubmed/31069957 http://dx.doi.org/10.1002/jia2.25283 Text en © 2019 RTI International. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Montgomery, Elizabeth T
Beksinska, Mags
Mgodi, Nyaradzo
Schwartz, Jill
Weinrib, Rachel
Browne, Erica N
Mphili, Nonhlanhla
Musara, Petina
Jaggernath, Manjeetha
Ju, Susan
Smit, Jenni
Chirenje, Z Mike
Doncel, Gustavo F
van der Straten, Ariane
End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
title End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
title_full End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
title_fullStr End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
title_full_unstemmed End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
title_short End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
title_sort end‐user preference for and choice of four vaginally delivered hiv prevention methods among young women in south africa and zimbabwe: the quatro clinical crossover study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506690/
https://www.ncbi.nlm.nih.gov/pubmed/31069957
http://dx.doi.org/10.1002/jia2.25283
work_keys_str_mv AT montgomeryelizabetht enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT beksinskamags enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT mgodinyaradzo enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT schwartzjill enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT weinribrachel enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT browneerican enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT mphilinonhlanhla enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT musarapetina enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT jaggernathmanjeetha enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT jususan enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT smitjenni enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT chirenjezmike enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT doncelgustavof enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy
AT vanderstratenariane enduserpreferenceforandchoiceoffourvaginallydeliveredhivpreventionmethodsamongyoungwomeninsouthafricaandzimbabwethequatroclinicalcrossoverstudy